Captopril and Valsartan May Improve Cognitive Function Through Potentiation of the Brain Antioxidant Defense System and Attenuation of Oxidative/Nitrosative Damage in STZ-Induced Dementia in Rat-Reference-Cited by-同舟云学术

Captopril and Valsartan May Improve Cognitive Function Through Potentiation of the Brain Antioxidant Defense System and Attenuation of Oxidative/Nitrosative Damage in STZ-Induced Dementia in Rat

Published:2016-12-22 Issue:4 Volume:6 Page:531-539
ISSN:2228-5881
Container-title:Advanced Pharmaceutical Bulletin
language:en
Short-container-title:Adv Pharm Bull

Author:

Arjmand Abbassi Yasaman,Mohammadi Mohammad Taghi,Sarami Foroshani Mahsa,Raouf Sarshoori Javad

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

Link

http://journals.tbzmed.ac.ir/APB/manuscript/APB-6-531.pdf

Reference47 articles.

1. Alzheimer’s Disease

2. Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease

3. Advances in the prevention of Alzheimer's disease and dementia

4. Neuropathological Alterations in Alzheimer Disease

5. Renin–angiotensin–aldosterone system has a pivotal role in cognitive impairment

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel artificial intelligence-based identification of drug-gene-disease interaction using protein-protein interaction;2024-06-03

2. Preliminary evaluation of the antiglycoxidant activity of verapamil using various in vitro and in silico biochemical/biophysical methods;Frontiers in Pharmacology;2023-11-28

3. Total Glucosides of Paeony Ameliorate Myocardial Injury in Chronic Heart Failure Rats by Suppressing PARP-1;Journal of Cardiovascular Translational Research;2023-10-13

4. The hypoglycemic effects of Juglans regia L. internal septum in type 2 diabetic patients: A double-blind, randomized, placebo-controlled clinical trial;Journal of Cardiovascular and Thoracic Research;2023-09-23

5. Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia;Pharmaceutics;2023-09-06